Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
Files
Publication date
2015-09-28
Authors
Horneff, G.
Ruperto, N.
Brunner, H.
Quartier, P.
Constantin, T.
Alexeeva, E.
Kone-Paut, I.
Marzan, K.
Wulffraat, Nico M.
Schneider, R.
Editors
Advisors
Supervisors
Document Type
Abstract
Metadata
Show full item recordCollections
License
Abstract
Keywords
Rheumatology, Immunology and Allergy, Pediatrics, Perinatology, and Child Health
Citation
Horneff, G, Ruperto, N, Brunner, H, Quartier, P, Constantin, T, Alexeeva, E, Kone-Paut, I, Marzan, K, Wulffraat, N, Schneider, R, Padeh, S, Chasnyk, V, Wouters, C, Deschner, J K, Kallinich, T, Lauwerys, B, Haddad, E, Nasonov, E, Trachana, M, Vougiouka, O, Abrams, K, Leon, K, Lheritier, K, Martini, A & Lovell, D 2015, 'Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever', Pediatric Rheumatology, vol. 13, no. Suppl. 1, O83. https://doi.org/10.1186/1546-0096-13-S1-O83